ARCHIVES

FDA Approves Erbitux for Head & Neck Cancer.

This article is from The Cancer Letter archive.

Vol. 32 No. 08 | March 3, 2006

Download PDF Visit The Full Archive

Related Articles

Post-Hoc Analysis of ThermoDox Suggests OS Improvement

January 31, 2014

DCT Board Okays Contract Recompetitions, But Litton Bionetics May Be Barred From Two Supporting Gall’s Lab, Plus FCRF Program

October 25, 1985

Oncogens Variations May Exaplin Susceptibility, Familial Cancer, USC Investigators Report

September 23, 1988

ASCO Urges Steps to Eliminate Cancer Care Disparities

May 22, 2009

Proflavine Bioassay Ineffective, NCI Says

July 15, 1977

In Brief: Cooperative Group Investigators Treat 10 For Every Patient In Protocols – Holland

October 31, 1975